{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T09:58:31Z","timestamp":1782554311604,"version":"3.54.5"},"reference-count":52,"publisher":"JLE","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T00:00:00Z","timestamp":1675555200000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie &amp; Th\u00e9rapeutique"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.nephro.2021.08.006","type":"journal-article","created":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T03:43:32Z","timestamp":1635565412000},"page":"45-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Drug-related problems in older patients with advanced chronic kidney disease identified during pretransplant comprehensive geriatric assessment"],"prefix":"10.1684","volume":"18","author":[{"given":"Marie-Anne","family":"Cerfon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Vernaudon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Gervais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Morelon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Coste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Krolak-Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Mouchoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teddy","family":"Novais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2021.08.006_bib0265","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1111\/ajt.15110","article-title":"Benefits of kidney transplantation for a national cohort of patients aged 70 years and older starting renal replacement therapy","volume":"18","author":"Legeai","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2021.08.006_bib0270","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/01.tp.0000259621.56861.31","article-title":"Renal transplantation in elderly patients older than 70 years of age: results from the scientific registry of transplant recipients","volume":"83","author":"Rao","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2021.08.006_bib0275","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.nephro.2016.07.453","article-title":"Ten-years trends in renal replacement therapy for end-stage renal disease in mainland France: lessons from the French Renal Epidemiology and Information Network (REIN) registry","volume":"13","author":"Vigneau","year":"2017","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nephro.2021.08.006_bib0280","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5414\/CNP60352","article-title":"The epidemic of aging in renal replacement therapy: an update on elderly patients and their outcomes","volume":"60","author":"Jager","year":"2003","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2021.08.006_bib0285","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/ckj\/sfz011","article-title":"The European Renal Association\u00a0\u2013\u00a0European Dialysis and Transplant Association (ERA\u00a0\u2013\u00a0EDTA) registry annual report 2016: a summary","volume":"12","author":"Kramer","year":"2019","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.nephro.2021.08.006_bib0290","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1600-6143.2012.04323.x","article-title":"Quantification of the early risk of death in elderly kidney transplant recipients","volume":"13","author":"Gill","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.nephro.2021.08.006_bib0295","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/ndt\/gfh022","article-title":"How great is the survival advantage of transplantation over dialysis in elderly patients?","volume":"19","author":"Oniscu","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2021.08.006_bib0300","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1097\/TXD.0000000000000770","article-title":"Improved health-related quality of life in older kidney recipients 1 year after transplantation","volume":"4","author":"L\u00f8nning","year":"2018","journal-title":"Transplant Direct"},{"key":"10.1016\/j.nephro.2021.08.006_bib0305","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.transproceed.2008.05.050","article-title":"Quality of life in renal transplant patients over 60 years of age","volume":"40","author":"Cornella","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.nephro.2021.08.006_bib0310","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1503\/cmaj.051291","article-title":"Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation","volume":"173","author":"Knoll","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.nephro.2021.08.006_bib0315","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/TP.0000000000001367","volume":"100","author":"Segall","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.nephro.2021.08.006_bib0320","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/ndt\/gfu216","article-title":"European renal best practice guideline on kidney donor and recipient evaluation and perioperative care","volume":"30","author":"Abramowicz","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2021.08.006_bib0325","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/jgs.12266","article-title":"Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis","volume":"61","author":"McAdams-DeMarco","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.nephro.2021.08.006_bib0330","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.archger.2016.10.007","article-title":"Frailty and chronic kidney disease: a systematic review","volume":"68","author":"Chowdhury","year":"2017","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.nephro.2021.08.006_bib0335","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.nephro.2014.08.002","article-title":"The essential of 2012 results from the French Renal Epidemiology and Information Network (REIN) ESRD registry","volume":"11","author":"Lassalle","year":"2015","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.nephro.2021.08.006_bib0340","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/ndt\/gfh771","article-title":"Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects","volume":"20","author":"Bailie","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2021.08.006_bib0345","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/sdi.12377","article-title":"Management of polypharmacy in dialysis patients","volume":"28","author":"St Peter","year":"2015","journal-title":"Semin Dial"},{"key":"10.1016\/j.nephro.2021.08.006_bib0350","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000494222","article-title":"Geriatric assessment in elderly patients with end-stage kidney disease","volume":"141","author":"Goto","year":"2019","journal-title":"Nephron"},{"key":"10.1016\/j.nephro.2021.08.006_bib0355","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2215\/CJN.14771218","article-title":"Geriatric assessment in advanced kidney disease","volume":"14","author":"Brown","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2021.08.006_bib0360","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/ckj\/sfz046","article-title":"Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study","volume":"12","author":"Schmidt","year":"2019","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.nephro.2021.08.006_bib0365","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/ndt\/gfaa064","article-title":"International prescribing patterns and polypharmacy in older people with advanced chronic kidney disease: results from the European Quality study","volume":"36","author":"Hayward","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2021.08.006_bib0370","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1345\/aph.1P627","article-title":"Prevalence of adverse drug events in ambulatory care: a systematic review","volume":"45","author":"Tach\u00e9","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.nephro.2021.08.006_bib0375","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40264-015-0378-5","article-title":"Appropriate polypharmacy and medicine safety: when many is not too many","volume":"39","author":"Cadogan","year":"2016","journal-title":"Drug Saf"},{"key":"10.1016\/j.nephro.2021.08.006_bib0380","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/ageing\/afz109","article-title":"New horizons in deprescribing for older people","volume":"48","author":"Woodford","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.nephro.2021.08.006_bib0385","unstructured":"Pharmaceutical Care Network Europe. PCNE Classification for drug related problems V8.02. (2017) www.pcne.org\/upload\/files\/230_PCNE_classification_V8-02.pdf."},{"key":"10.1016\/j.nephro.2021.08.006_bib0390","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1365-2125.2003.02029.x","article-title":"A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals","volume":"57","author":"Dooley","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.nephro.2021.08.006_bib0395","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s11096-019-00816-4","article-title":"Clinical pharmacy practice in the care of chronic kidney disease patients: a systematic review","volume":"41","author":"Al Raiisi","year":"2019","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.nephro.2021.08.006_bib0400","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/0149-2918(95)80084-0","article-title":"Drug interactions in transplantation","volume":"17","author":"Seifeldin","year":"1995","journal-title":"Clin Ther"},{"key":"10.1016\/j.nephro.2021.08.006_bib0405","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2165\/00003088-200241110-00003","article-title":"Mechanisms of clinically relevant drug interactions associated with tacrolimus","volume":"41","author":"Christians","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.nephro.2021.08.006_bib0410","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psy Res"},{"key":"10.1016\/j.nephro.2021.08.006_bib0415","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"Assessment of older people: self-maintaining and instrumental activities of daily living","volume":"9","author":"Lawton","year":"1969","journal-title":"Gerontologist"},{"key":"10.1016\/j.nephro.2021.08.006_bib0420","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.nephro.2021.08.006_bib0425","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11096-006-9027-5","article-title":"Validation of an instrument for the documentation of clinical pharmacists\u2019 interventions","volume":"28","author":"Allenet","year":"2006","journal-title":"Pharm World Sci PWS"},{"key":"10.1016\/j.nephro.2021.08.006_bib0430","series-title":"Norwegian Institute of Public Health and World Health Organization. Guideline for ATC classification and DDD assignment","year":"2021"},{"key":"10.1016\/j.nephro.2021.08.006_bib0435","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11096-015-0199-8","article-title":"Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands","volume":"38","author":"Chau","year":"2016","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.nephro.2021.08.006_bib0440","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s11096-017-0587-3","article-title":"Drug-related problems among community-dwelling older adults in mainland China","volume":"40","author":"Yang","year":"2018","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.nephro.2021.08.006_bib0445","doi-asserted-by":"crossref","first-page":"782","DOI":"10.5301\/jn.5000063","article-title":"Identification of drug-related problems in ambulatory chronic kidney disease patients: a 6-month prospective study","volume":"25","author":"Belaiche","year":"2012","journal-title":"J Nephrol"},{"key":"10.1016\/j.nephro.2021.08.006_bib0450","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s11096-018-0651-7","article-title":"Medication-related problems among adult chronic kidney disease patients in a sub-Saharan tertiary hospital","volume":"40","author":"Njeri","year":"2018","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.nephro.2021.08.006_bib0455","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/pharmacy6030076","article-title":"Polypharmacy and medication-related problems in hemodialysis patients: a call for deprescribing","volume":"6","author":"Alshamrani","year":"2018","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.nephro.2021.08.006_bib0460","doi-asserted-by":"crossref","first-page":"1504371","DOI":"10.1155\/2019\/1504371","article-title":"Drug-related problems and associated factors among patients admitted with chronic kidney disease at Jimma University Medical Center, Jimma Zone, Jimma, Southwest Ethiopia: a hospital-based prospective observational study","volume":"2019","author":"Garedow","year":"2019","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.nephro.2021.08.006_bib0465","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/postgradmedj-2012-130889","article-title":"The prevalence of potentially inappropriate medication prescribing in elderly patients with chronic kidney disease","volume":"89","author":"Jones","year":"2013","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.nephro.2021.08.006_bib0470","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/ndt\/gfu070","article-title":"Prescription of potentially inappropriate medications to elderly hemodialysis patients: prevalence and predictors","volume":"30","author":"Kondo","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2021.08.006_bib0475","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00228-019-02727-9","article-title":"Effectiveness of using STOPP\/START criteria to identify potentially inappropriate medication in people aged \u226565 years with chronic kidney disease: a randomized clinical trial","volume":"75","author":"Parker","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.nephro.2021.08.006_bib0480","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12877-020-1485-4","article-title":"Medication burden and inappropriate prescription risk among elderly with advanced chronic kidney disease","volume":"20","author":"Roux-Marson","year":"2020","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.nephro.2021.08.006_bib0485","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/1060028019871891","article-title":"Clinical controversy in transplantation: tacrolimus versus cyclosporine in statin drug interactions","volume":"54","author":"Migliozzi","year":"2020","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.nephro.2021.08.006_bib0490","first-page":"243","article-title":"Evaluating the quality of pharmacists\u2019 interventions in older patient than 75 years","volume":"32","author":"Ziane","year":"2013","journal-title":"J Phar Clin"},{"key":"10.1016\/j.nephro.2021.08.006_bib0495","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2147\/CIA.S109048","article-title":"Impact of pharmacist interventions in older patients: a prospective study in a tertiary hospital in Germany","volume":"11","author":"Cortejoso","year":"2016","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.nephro.2021.08.006_bib0500","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association","volume":"152","author":"Freedberg","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2021.08.006_bib0505","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s40266-018-0593-8","article-title":"The role of deprescribing in older adults with chronic kidney disease","volume":"35","author":"Triantafylidis","year":"2018","journal-title":"Drugs Aging"},{"key":"10.1016\/j.nephro.2021.08.006_bib0510","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40266-020-00747-0","article-title":"Adverse drug events in patients with chronic kidney disease associated with multiple drug interactions and polypharmacy","volume":"37","author":"Sommer","year":"2020","journal-title":"Drugs Aging"},{"key":"10.1016\/j.nephro.2021.08.006_bib0515","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1681\/ASN.2017020201","article-title":"Should statins be banned from dialysis?","volume":"28","author":"De Vriese","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2021.08.006_bib0520","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40520-015-0359-7","article-title":"Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence","volume":"28","author":"Collamati","year":"2016","journal-title":"Aging Clin Exp Res"}],"container-title":["N\u00e9phrologie &amp; Th\u00e9rapeutique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725521005320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725521005320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2021.08.006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T15:55:25Z","timestamp":1741190125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725521005320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1769725521005320"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2021.08.006","relation":{},"ISSN":["1769-7255"],"issn-type":[{"value":"1769-7255","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-related problems in older patients with advanced chronic kidney disease identified during pretransplant comprehensive geriatric assessment","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2021.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 francophone de n\u00e9phrologie, dialyse et transplantation. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}